Exercise Training and Cognitive Function in Kidney Disease
| Status: | Recruiting |
|---|---|
| Conditions: | Renal Impairment / Chronic Kidney Disease |
| Therapuetic Areas: | Nephrology / Urology |
| Healthy: | No |
| Age Range: | 60 - 80 |
| Updated: | 10/19/2018 |
| Start Date: | September 1, 2017 |
| End Date: | September 1, 2019 |
| Contact: | Ulf G Bronas, PhD |
| Email: | bronas@uic.edu |
| Phone: | 312-355-5886 |
Chronic kidney disease (CKD), affects over 45% of all individuals over 70 years of age.
Patients with moderate CKD have more than a two-fold increased risk of cognitive impairment
than those without CKD; furthermore, as many as 20-70% of patients with CKD have established
cognitive impairment and overt dementia. The burden of cognitive impairment and dementia
leads to functional decline and accelerated loss of independence, contributing to the
tremendous individual, societal, and economic burden of CKD (i.e., 20% of Medicare
expenditures in adults >65 years of age). There is no recommended treatment to prevent
cognitive decline in CKD patients, and the few medications available for cognitive impairment
have only short term modest effects. There is a critical need to evaluate therapies to
forestall cognitive impairment, and maintain or improve cognitive functioning in older
patients with CKD. To address this need, this study will test the hypothesis that older
patients with moderate/severe CKD and pre-clinical cognitive impairment randomized to a
6-month home-based exercise program will improve cognitive function and MRI measured brain
structure, compared to a usual care control group. This study will combine an assessment of
cognition with MR imaging techniques to fully evaluate brain structure, blood flow, and
behavior relationships at a level previously not conducted in this population
Patients with moderate CKD have more than a two-fold increased risk of cognitive impairment
than those without CKD; furthermore, as many as 20-70% of patients with CKD have established
cognitive impairment and overt dementia. The burden of cognitive impairment and dementia
leads to functional decline and accelerated loss of independence, contributing to the
tremendous individual, societal, and economic burden of CKD (i.e., 20% of Medicare
expenditures in adults >65 years of age). There is no recommended treatment to prevent
cognitive decline in CKD patients, and the few medications available for cognitive impairment
have only short term modest effects. There is a critical need to evaluate therapies to
forestall cognitive impairment, and maintain or improve cognitive functioning in older
patients with CKD. To address this need, this study will test the hypothesis that older
patients with moderate/severe CKD and pre-clinical cognitive impairment randomized to a
6-month home-based exercise program will improve cognitive function and MRI measured brain
structure, compared to a usual care control group. This study will combine an assessment of
cognition with MR imaging techniques to fully evaluate brain structure, blood flow, and
behavior relationships at a level previously not conducted in this population
Inclusion Criteria:
- English speaking men and women
- diagnosed stage 3-5 CKD (eGFR<60 to 15 ml/min);
- 60-80 years of age,
- self-experienced persistent decline in cognitive capacity determined as self-reported
cognitive complaint (i.e., answering "yes" to the question: "Do you feel like your
memory or thinking skills have gotten worse recently?" (before any clinical impairment
of cognition has occurred)
- ability to undergo an MRI;
- no history of major head trauma.
Exclusion Criteria:
- • current/past diagnosis of neurological/psychiatric disorders;
- any medications to improve cognition or mood;
- Diagnosed Dementia or a score of <2 on the mini-cog assessment
- Ischemic ulcerations or gangrene on the feet or legs;
- Participating in a supervised exercise program with intent to increase fitness
levels 3 days/week,
- Requires assistive ambulation;
- Limited exercise capacity due to conditions other than claudication
- unstable angina,
- Claudication
- severe arthritis,
- extreme dyspnea on exertion,
- unstable coronary artery disease;
- Class III-IV heart failure;
- Current uncontrolled sustained arrhythmias,
- severe/symptomatic aortic or mitral stenosis,
- hypertrophic obstructive cardiomyopathy,
- severe pulmonary hypertension,
- active myocarditis/pericarditis,
- thrombophlebitis,
- recent systemic/pulmonary embolus (within 3 months);
- Resting systolic BP >200 mmHg or resting diastolic BP >110 mmHg;
- Revascularization procedures within the previous 6 months;
- Any unforeseen illness or disability that would preclude exercise testing or
training based on patient provider opinion;
- Pregnancy
- No diagnosis of CKD
- One or more contraindication for MRI
- cardiac pacemaker,
- aneurysm clip,
- cochlear implants,
- shrapnel,
- history of metal fragments in eyes,
- neurostimulators,
- diagnosed claustrophobia.
We found this trial at
1
site
2035 W Taylor St
Chicago, Illinois
Chicago, Illinois
(312) 996-4350
Principal Investigator: Ulf G Bronas, PhD
Phone: 312-355-5886
University of Illinois at Chicago A major research university in the heart of one of...
Click here to add this to my saved trials
